C21H19ClN2O8
Neat
462.8
Oxazepam glucuronide; 6801-81-6; 26IK2C76NO; DTXSID701028080; beta-D-Glucopyranosiduronic acid, 7-chloro-2, 3-dihydro-2-oxo-5-phenyl-1H-1, 4-benzodiazepin-3-yl; (2S, 3S, 4S, 5R, 6S)-6-((7-chloro-2-hydroxy-5-phenyl-3H-1, 4-benzodiazepin-3-yl)oxy)-3, 4, 5-trihydroxyoxane-2-carboxylic acid; (2S, 3S, 4S, 5R, 6S)-6-[(7-chloro-2-hydroxy-5-phenyl-3H-1, 4-benzodiazepin-3-yl)oxy]-3, 4, 5-trihydroxyoxane-2-carboxylic acid; RefChem:168847; DTXCID601513648; (2S, 3S, 4S, 5R, 6S)-6-[(7-chloro-2-oxo-5-phenyl-1, 3-dihydro-1, 4-benzodiazepin-3-yl)oxy]-3, 4, 5-trihydroxyoxane-2-carboxylic acid; UNII-26IK2C76NO; Oxazepam-glucuronide; Oxazepam glucuronide solution; SCHEMBL29412419; DTXSID40951163; CHEBI:168654; NS00009627; Q27254098; 7-Chloro-2-hydroxy-5-phenyl-3H-1, 4-benzodiazepin-3-yl hexopyranosiduronic acid; .BETA.-D-GLUCOPYRANOSIDURONIC ACID, 7-CHLORO-2, 3-DIHYDRO-2-OXO-5-PHENYL-1H-1 and 4-BENZODIAZEPIN-3-YL
(2S, 3S, 4S, 5R, 6S)-6-[(7-chloro-2-oxo-5-phenyl-1, 3-dihydro-1, 4-benzodiazepin-3-yl)oxy]-3, 4 and 5-trihydroxyoxane-2-carboxylic acid
InChI=1S/C21H19ClN2O8/c22-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)24-19(18(28)23-12)32-21-16(27)14(25)15(26)17(31-21)20(29)30/h1-8,14-17,19,21,25-27H,(H,23,28)(H,29,30)/t14-,15-,16+,17-,19?,21-/m0/s1